Member Info for Borsaci06

Security MTP / Midatech Pharma PLC (59564R104)
Latest Market Date 2020-08-27
Short Volume 108,975
Market Volume 699,700
Short Volume Ratio 16%

sorry, could not be more help

Steadydanny
that was 5 min check
know nothing about sareum (sar)
find that Viveka is the master on Midatech (mtph), think you already know this

* Partner ..........................................................Programme
SRI International ............................... TYK2/JAK1 (Autoimmune)
Chinese Specialty Pharma (un-named)..... FLT3+Aurora
http://www.sareum.com/partners/current-collaborations/

* China Medical Systems http://en.cms.net.cn/CmsNewWebEn/index.aspx
https://www.proactiveinvestors.co.uk/companies/news/215325/midatech-pharma-soars-as-chinese-licensing-deal-is-approved-215325.html

only connection I can find is this " Chinese Specialty Pharma (un-named) & China Medical Systems "

wonder if both are same copmany
needs verifying

imho

not only that these as well to come

· 336,036 Ordinary Shares issuable upon the exercise of stock options outstanding under our equity incentive plans at a weighted-average exercise price of £8.487 per share;

· 2,857 Ordinary Shares issuable upon the exercise of stock options assumed in connection with the acquisition of DARA BioSciences, Inc., or DARA, at a weighted average exercise price of $101.26 per share;

· warrants exercisable for 15,692,276 Ordinary Shares at an exercise price of £10.00 per share;

· warrants exercisable for 4,624 Ordinary Shares assumed in connection with the acquisition of DARA at an exercise price of $110.51 per share

· warrants, issued in connection with the October Private Placement, exercisable for 630,000 Depositary Shares (representing 3,150,000 Ordinary Shares), at an exercise price of $6.25 per Depositary Share;

link is below Sir,
page 12

http://otp.investis.com/clients/us/midatech/SEC/sec-show.aspx?Type=html&FilingId=14331812&CIK=0001643918&Index=10000

http://www.midatechpharma.com/sec-filings

"" exercise of stock options outstanding under our equity incentive plans at a weighted-average exercise price of £8.487 per share ""

also
would like
those to exercise their options @ £8.487 if/when ?

** mtph announces it has entered into a research collaboration for the Q-Sphera platform with a European affiliate of a global pharmaceutical company

I like to know the name of company

** received a letter purporting to terminate the agreement between Secura Bio Inc. ("Secura Bio") and Midatech Limited, a subsidiary of the Company, dated 5 June 2017 (the "Letter"), related to the licence of certain patents of panobinostat

like an update on this

ChrisToffer
totally agree

ChrisToffer
the post below is from 13/07/2020
after I posted that seb24 filtered me

" 13 Jul 2020 15:57
nolupus
can we assume/speculate that
letting friends in or something else

seb24 was guessing a leak
wonder if he found & plugged it "

RNS ( The Regulatory News Service )
transmits regulatory and non-regulatory information published by companies and organisations allowing them to comply with local market transparency legislation

since when there are:
RWS ( regulatory webinar service )
RIS ( regulatory interview service )

It’s good to have all those &
cheeky posts &
changed subject as well

" The skin has many immune competent cells such as Langerhans cells; T lymphocytes When antigens (bacteria, fungi, viruses) enter the skin; Langerhans cells appear to capture antigens. The keratinocytes secrete INTERFERON "
https://twitter.com/drle111086/status/1298915423212060673

" However, those from KC activated with the potent IFN inducer, polyriboinosinic:polriboycytidylic acid (poly rI:rC), had appreciable antiviral activity, which studies with neutralizing sera showed to be caused by IFN-beta "
https://pubmed.ncbi.nlm.nih.gov/9452359/

" only women have an interferon response that holds up (type I and II) "

@MARYau_MCU_PH
Le papier de nature sur la différence homme-femme dans le covid19. Mieux que la reprise de l'express.
A soulever: seuls les femmes ont une réponse interferon qui tient la route (type I et II).
Translated from French by
Nature's paper on the difference between men and women in covid19. Better than the resumption of the express.
To raise: only women have an interferon response that holds up (type I and II)
https://twitter.com/MARYau_MCU_PH/status/1298919522540425216

26 August 2020
https://www.nature.com/articles/s41586-020-2700-3.epdf?sharing_token=XwQ_DhYGF8kgo8YG6XbWE9RgN0jAjWel9jnR3ZoTv0OnEizbEix-e5oQBbSAv4RuMbX7gVDmw3x3Hy4DL5cry0xA3S-Z4KrUaHCVUOS0KJkUb-0nzpac6P7xR2tboxgn-A4qRQyOrvRdj4G8GhWgyjXl0XDLFsMjkSga3sEXJ6c%3D

another company announcing positve results of their BBT-032: A long-acting beta interferon analog for treating multiple sclerosis and dementia, against sars2.

evidence has been mounting !!

Bolder BioTechnology announces positive preclinical data for BBT-032 to inhibit growth of the SARS-CoV-2 virus
https://www.innovationews.com/Bolder-BioTechnology-announces-positive-preclinical-data-for-BBT-032-to-inhibit-growth-of-the-SARS-CoV-2-virus/

http://www.bolderbio.com/pipeline/bbt-032/

the word " fool " is embedded in the mind
before you read the article,
tells me the agenda

agree RichTheNewbie
they use fundamentals biotech discovery stock to meet their agenda ( generally to short it )

** to watch a replay of the webinar hosted 20 July 2020
https://www.lsegissuerservices.com/spark/Synairgen/events/97cda0b9-0529-4be1-b1ca-471cc8dc1e94

** Dr. John Campbell ( posted before )
https://www.youtube.com/watch?v=wqDd7ixh184

** expert reaction to announcement by Synairgen
https://www.sciencemediacentre.org/expert-reaction-to-announcement-by-synairgen-that-their-drug-sng001-has-had-positive-results-in-initial-trials-on-covid-19-patients/?cli_action=1598515300.005

can get some info from those to help make your mind up
hold/sell/buy more/trade

if / when you think / expect,
the results of Home-part of trail is going to be no better ( worse ) than hospital-part
then,
it is time to sell

imho

not in my case

I am expecting the results RNS around mid-september

seeking / asking for reassurances as result day nears differs from planting a fear